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In the case of the Ago hook in 
NRPD1b, how does an RNA poly-
merase-associated AGO4 protein 
affect transcription, transcript rec-
ognition, and siRNA-guided DNA 
methylation? Recent evidence sug-
gests that NRPD1b may generate 
Pol IVb transcripts primed by an 
siRNA and may be involved in the 
siRNA-mediated targeting of het-
erochromatin (Pontes et al., 2006). 
It is not clear how AGO4 modulates 
the functions of NRPD1b relative to 
those of NRPD1a, which may pos-
sess genuine DNA- or RNA-depen-
dent RNA polymerase activity. The 
Tas3 Ago hook is necessary for the 
establishment rather than mainte-
nance of Ago1-mediated centro-
meric silencing (Partridge et al., 
2007). Moreover, it is possible that 
Ago hooks have important functions 
beyond recruitment (Buhler et al., 
2006). In support of this hypothesis, 
Ago hooks bind to the PIWI domain 
of Ago proteins (Behm-Ansmant et 
al., 2006; Till et al., 2007), a func-
tionally critical domain that harbors 
siRNA-mediated “slicer” activity 
and recognizes the “seed” region 
in miRNAs. In fact, site-directed 
mutagenesis of human Ago2 PIWI 
domains and competition assays 
suggest that Ago hooks are revers-
ibly bound by the same surface that 
normally recognizes the 5′ end of 
guide siRNAs or miRNAs (Till et al., 
2007). Consistent with binding to 
this critical region in PIWI domains, 
Ago hook peptides relieve trans-
lational repression mediated by an 
miRNA in Drosophila extracts. It is 
therefore possible that the unusual 
CTD of NRPD1b not only mediates 
recruitment of AGO4 to the poly-
merase but also helps to regulate 
AGO4 function, for example by 
binding to it in a reversible man-
ner, perhaps switching its ability to 
“slice” an RNA target into a hom-
ing function for DNA target regions. 
The El-Shami et al. study clearly 
shows that in plants RNA Pol IVb 
complexes use an Ago hook for 
AGO4-dependent DNA methylation 
in vivo. Future work will address 
how the fine-tuning of the dynamic 
interactions between AGO4 and 
Pol IVb determines the specialized 
transcription and RNAi processes 
that are required to silence the plant 
genome.
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There are two molecular machineries for pre-mRNA splicing—the major spliceosome and 
the minor spliceosome. In this issue of Cell, König et al. (2007) demonstrate that the two 
splicing pathways are spatially separated in the cell and may have distinct functions.Gene expression in eukaryotes requires 
the removal of noncoding intervening 
intron sequences by the spliceosome 
to form the mature mRNA. There are two distinct spliceosome complexes. 
The major spliceosome comprises five 
small nuclear ribonucleoprotein parti-
cles (snRNPs), U1, U2, U4, U5, and U6, Cell 131, Noand a multitude of non-snRNP splicing 
factors (Jurica and Moore, 2003). More 
recently, a structurally and function-
ally analogous second spliceosome vember 16, 2007 ©2007 Elsevier Inc. 645
that mediates the excision of a 
minor class of introns harbor-
ing noncanonical consensus 
sequences has been discov-
ered (Patel and Steitz, 2003; 
Will and Luhrmann, 2005). This 
spliceosome, referred to as the 
minor spliceosome, comprises 
four unique snRNPs, U11, U12, 
U4atac, and U6atac, as well as 
the U5 snRNP, which is shared 
with the major spliceosome 
(Hall and Padgett, 1996; Tarn 
and Steitz, 1996). Since its dis-
covery, the physiological sig-
nificance of the minor splicing 
pathway has been a mystery. 
In this issue, König et al. (2007) 
now show that the two path-
ways are spatially segregated 
in the cell and may act on dis-
tinct sets of genes (Figure 1).
The first dramatic indication 
of fundamental differences 
between the two splicing 
pathways became clear when 
König et al. looked at the cellu-
lar localization of spliceosome 
components. In situ hybridiza-
tion on tissue sections from 
adult zebrafish revealed perinuclear 
and cytoplasmic staining for the minor 
spliceosome components U12 and 
U6atac, compared to the well-estab-
lished nuclear distribution of the U2 
snRNA of the major spliceosome. A 
similar localization pattern was found 
in mammalian cultured cells, establish-
ing that differential cellular localization 
of major- and minor-class snRNAs is a 
conserved feature in vertebrates.
Three lines of evidence suggest 
that the cytoplasmic pool of U12 
and U6atac is functionally active. 
First, transcripts with unspliced 
minor introns are found in the cyto-
plasm. Second, selective inhibition 
of minor-class splicing in the cyto-
plasm—elegantly achieved using 
an U6atac antisense morpholino 
conjugated to a nuclear-export 
sequence—results in accumula-
tion of unspliced U12-type introns 
in the cytoplasm. Finally, the minor 
spliceosome, unlike its major coun-
terpart, is active during mitosis. 
These results extend recent find-
ings of U2-dependent splicing in 
the cytoplasm of platelets and den-
dritic cells (Denis et al., 2005; Glan-
zer et al., 2005), which might have 
represented a peculiarity of those 
systems, thereby making a more 
general case for the existence of 
splicing in the cytoplasm.
The differential localization of 
major and minor splicing compo-
nents allowed for the tantalizing 
possibility that they exert distinct 
cellular roles. To address this, König 
et al. investigated the function of the 
minor spliceosome at the organ-
ismal level in developing zebrafish 
embryos. Upon specific inhibition 
of the major or minor spliceosome 
using antisense morpholinos to U2 or 
U12 (U6atac) snRNAs, respectively, 
they found distinct requirements for 
the two spliceosomes in develop-
ment. Interference with U2-mediated 
splicing caused early developmen-
tal arrest, whereas interference with 
the minor spliceosome had an effect 
later in development. The observed 
phenotypes after inhibition of U12-
mediated splicing pointed to a role 
of minor-class splicing in 
cell proliferation and indeed 
interference with minor spli-
ceosome function blocks cell-
cycle progression in zebrafish 
and in mammalian cells. 
Consistent with this notion, 
downregulation of U11/U12-
specific proteins in HeLa cells 
is known to affect cell viability 
(Will et al., 2004).
These results suggest a 
division of labor between 
the two spliceosomes (Fig-
ure 1). The full functional 
and physiological relevance 
of cytoplasmic splicing is, 
however, not entirely clear. 
For example, it appears that 
some minor splicing does 
occur in the nucleus and 
it is not known whether all 
or only a specific subset of 
U12-type-containing RNAs 
are spliced in the cytoplasm. 
Furthermore, it has not been 
shown formally that a lack 
of cytoplasmic U12 splicing 
activity is responsible for 
the developmental defects 
in zebrafish embryos; nuclear minor 
splicing also may contribute.
What is the advantage of seques-
tering the two splicing pathways in 
different cellular locations? It cannot 
be excluded that minor splicing in the 
cytoplasm simply occurs by default on 
any U12-type intron-containing RNA. 
However, it is possible that, just as for 
cytoplasmic U2 splicing in platelets, 
U12 splicing in the cytoplasm is a 
tightly regulated process represent-
ing an additional layer of gene regu-
lation for U12-intron-containing tran-
scripts. Circumstantial support for 
this possibility comes from the fact 
that both types of known cytoplasmi-
cally spliced RNAs—signaling com-
ponents in platelets and proliferation 
factors that act during late embryonic 
development—are temporally tightly 
regulated in their respective cell 
types. Identification of the full com-
plement of cytoplasmically spliced 
transcripts in various physiological 
situations should provide insights into 
the functional relevance of cytoplas-
mic splicing in gene regulation.
figure 1. segregated splicing
Subcellular localization and function of major and minor 
pre-mRNA splicing pathways. The major splicing pathway 
removes U2-type introns allowing the adjacent exons (blue) 
to be spliced together in the nucleus before export of the 
fully spliced transcripts to the cytoplasm. Transcripts that 
also contain U12-type introns are exported as partially spliced 
transcripts and their exons (orange) are spliced together by 
the U12 pathway in the cytoplasm. The mechanism by which 
they evade RNA surveillance in the nucleus is unknown. Al-
though U2-type introns are found globally, results from König 
et al. (2007) suggest that U12-type introns may occur prefer-
entially in particular sets of genes such as those involved in 
cellular proliferation.646 Cell 131, November 16, 2007 ©2007 Elsevier Inc.
An interesting implication from this 
work is the issue of how mRNAs that 
harbor unspliced U12-type introns 
escape from the nucleus (Figure 1). 
Normally, incompletely spliced RNAs 
are retained in the nucleus until they 
are fully processed or they are targeted 
for degradation. The fate of a newly 
spliced RNA is typically determined 
by the deposition of the exon-junction 
complex (EJC), which assembles over 
newly joined exons immediately after 
splicing and promotes export of cor-
rectly spliced RNA. It is possible that 
the presence of the EJC on multiple 
spliced U2-type exons in U12-con-
taining RNAs is sufficient to mark it 
for export. On the other hand, specific 
factors might exist that recognize the 
partially spliced U12-type RNAs, pre-
vent their degradation, and facilitate 
their nuclear export. Interestingly, this 
situation is akin to the fate of mRNAs 
that retain intronic sequences as part 
of their normal alternative splicing but 
are nevertheless exported.Lysosomes are acidic intracellular 
organelles where many proteins, lip-
ids, and other macromolecules are 
delivered for degradation by lyso-
somal acid hydrolases. Ever since the 
discovery of lysosomes by de Duve 
and colleagues (de Duve et al., 1955), 
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Most lysosomal proteins are 
recognition and transport to th
pathway for protein sorting to
lysosomal enzyme defective i
some through its interaction wThe results reported by König et 
al. might also have implications for 
how we think about the evolution of 
splicing. The minor spliceosome has 
an early evolutionary origin (Russell 
et al., 2006). U2-type splice junctions 
are far more degenerate than U12-
type junctions, suggesting that U12-
exons were at one point dominant and 
U2-exons evolutionarily derived from 
them. Although provocative, it raises 
the question of whether more, or even 
all, pre-mRNA splicing at one point in 
time occurred in the cytoplasm. The 
correct expression of the more com-
plex genes and genomes of higher 
organisms might have required closer 
coordination of pre-mRNA splicing 
and quality control with transcription, 
therefore favoring migration of the 
splicing reaction to the cell nucleus. 
Thus, the discovery of splicing in the 
cytoplasm provides a glimpse into the 
distant past, while also opening up a 
new vista on the future of pre-mRNA 
splicing.Cell 131, Nove
much of our understanding of how 
proteins are trafficked to this com-
partment and how they function has 
come from studies on a wide range 
of lysosomal storage diseases. In this 
family of genetic diseases, defects in 
the function of the lysosome results 
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in mis-sorting or loss of function of 
lysosomal proteins with deleterious 
consequences. In the case of the lys-
osomal storage disease Inclusion-cell 
(I-cell) disease, lysosomal dysfunc-
tion is caused by secretion of most 
lysosomal enzymes from the cell. 
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